Global therapeutic and probiotic markets projected for significant growth

Recent market research reports indicate significant growth projections for both the protein degradation therapeutics (PROTAC) sector and the probiotic personal care products market.

The global PROTAC market, valued at USD 1.46 billion in 2025, is projected to reach USD 7.90 billion by 2033 with a compound annual growth rate (CAGR) of 23.50%. This sector focuses on targeting disease-causing proteins for degradation, particularly in oncology, neurodegenerative diseases, and immunological disorders. Small molecules are expected to lead this segment.

In the personal care sector, the global probiotic products market is valued at USD 39.00 billion in 2025 and is expected to grow to USD 130.52 billion by 2033, representing a CAGR of 16.30%. Skincare products are expected to dominate this market, with significant growth observed in online retail distribution channels.